Vaccines, blood, antisera, toxins and cultures in   Czechia

Exports In 2022, Czechia exported $634M in Vaccines, blood, antisera, toxins and cultures, making it the 24th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 69th most exported product in Czechia. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Czechia are: Netherlands ($106M), Slovakia ($93.8M), Germany ($84.9M), Austria ($68.5M), and Ireland ($49.4M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Czechia between 2021 and 2022 were Netherlands ($42.6M), Slovakia ($19.2M), and United Kingdom ($17.5M).

Imports In 2022, Czechia imported $1.85B in Vaccines, blood, antisera, toxins and cultures, becoming the 26th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 18th most imported product in Czechia. Czechia imports Vaccines, blood, antisera, toxins and cultures primarily from: Germany ($645M), Belgium ($284M), Switzerland ($242M), Hungary ($112M), and Netherlands ($109M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Czechia between 2021 and 2022 were Belgium ($66.2M), Netherlands ($39.6M), and Hungary ($32.5M).